Myeloma Trial, Recruiting NCT01676805 Sponsor: National Cancer Institute (NCI) Condition: Myeloma
Back to Myeloma

Myeloma Trial, Recruiting

NCT01676805
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If you have a known blood cancer (lymphoid malignancy):

  • You have been diagnosed with a lymphoid blood cancer or a condition that may lead to one, such as multiple myeloma, Hodgkin's lymphoma, diffuse large B-cell lymphoma, or similar conditions
  • Your diagnosis has been or can be confirmed using tissue samples reviewed by the NCI Laboratory of Pathology
  • You are 18 years of age or older
  • You are generally able to carry out daily activities and care for yourself (your doctor will assess this)
  • You, or a legally authorized person acting on your behalf, are able and willing to sign a consent form

If you do NOT have a known blood cancer:

  • You are scheduled for a surgical procedure during which blood or normal lymph node or tissue samples could be collected for research
  • You are considered medically suitable for the planned surgery
  • You are 18 years of age or older
  • You are able and willing to sign a consent form

Optional blood collection procedure (apheresis) — only if you qualify and agree:

  • Your hemoglobin and platelet levels are at an acceptable level (confirm with trial site)
  • You weigh more than 25 kg (approximately 55 lbs)
  • You have tested negative for HIV
  • Your blood clotting levels are within the normal range
  • You have suitable vein access or an existing central line already in place for medical reasons

Who may not be able to join:

If you have a known blood cancer:

  • You are currently pregnant
  • You have a serious active condition affecting a major organ, such as heart disease, a recent heart attack, heart failure, or significant breathing problems, which could make biopsies or blood collection procedures more risky
  • You have an active medical or mental health condition that could increase risk or prevent you from giving informed consent, as determined by the lead doctor

If you do NOT have a known blood cancer:

  • You are currently pregnant
  • You currently have another active cancer (note: certain past skin cancers that were fully treated, early-stage melanoma, or cancers treated with curative intent with no signs of disease for 2 or more years may still be eligible — confirm with trial site)
  • You have an active medical or mental health condition that could increase risk or prevent you from giving informed consent, as determined by the lead doctor

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christopher J Melani, M.D., National Cancer Institute (NCI)

Phone: (888) 624-1937

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 September 2012

Where this trial is recruiting

Jamaica 🇺🇸 United States

Primary endpoints

sample acquisition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov